ReviewJournal of advanced research2026
Assembly delivery of bioactive matters: Advances, challenges, and prospects.
Review in Journal of advanced research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- 4D nanoimaging-guided smart therapeutics: spatiotemporal control of disease microenvironments.RSC advances · 2026Review
- High intestinal iron absorption induced by decreased hepcidin leads to imbalance of iron metabolism in aging mice.Biogerontology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAssembled delivery systems (ADS) are a novel drug delivery technology that has emerged in biomedical engineering in recent years. By integrating molecular self-assembly with intelligent functional materials, ADS enables efficient delivery of drugs, genes, and bioactive substances. Compared to conventional delivery systems, ADS offer advantages such as tunable structure, controllable function, and precise responsiveness, demonstrating great potential in targeted therapy, tissue regeneration, and disease diagnosis. However, systematic conceptualization and in-depth research on ADS remain limited. AIM OF REVIEW: This review aims to clarify the fundamental principles, functional characteristics, and multidisciplinary applications of ADS. It elucidates their material design, self-assembly mechanisms, and delivery strategies, emphasizes core advantages of ADS, and outlines current challenges and future directions. It provides theoretical support and technical pathways for developing intelligent, efficient, and personalized ADS, accelerating their translation from laboratory research to clinical application. KEY SCIENTIFIC CONCEPTS OF REVIEW: The core principle of ADS lies in the synergistic integration of molecular self-assembly and stimulus-responsive smart materials, enabling the rational design of carriers with precise structure-function relationships for the intelligent delivery of bioactive agents. Key advantages of ADS include precise targeting through multi-level strategies, intelligent responsiveness, multimodal synergy, enhanced biocompatibility, and flexible engineering. Representative breakthroughs have been achieved in drug delivery, tissue engineering, and gene editing. Furthermore, the convergence of ADS with emerging technologies, such as artificial intelligence and microfluidics, offers a strategic pathway toward next-generation systems that are efficient, intelligent, and highly precise, establishing new paradigms for biomedical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.